Publicaciones en las que colabora con Antonio C. Gómez García (27)

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667

  2. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

2000

  1. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics

    Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564

  2. The microbiology of moxifloxacin

    Drugs of Today, Vol. 36, Núm. 4, pp. 215-227

1999

  1. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 357-359

  2. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180

1994

  1. TRATAMIENTO CON CIPROFLOXACINO DE LAS INFECCIONES GRAVES EN PACIENTES HOSPITALIZADOS. ESTUDIO RETROSPECTIVO

    Revista Espanola de Quimioterapia, Vol. 7, Núm. 4, pp. 286-291

1989

  1. ACTIVIDAD COMPARATIVA IN VITRO DE CEFUROXIMA Y OTROS DIEZ ANTIMICROBIANOS FRENTE A 4.678 AISLADOS DE PACIENTES NO HOSPITALIZADOS

    Revista Espanola de Quimioterapia, Vol. 2, Núm. 2, pp. 179-185

  2. EFICACIA CLINICA Y TOLERANCIA DE CIPROFLOXACINA EN EL TRATAMIENTO DE INFECCIONES RESPIRATORIAS DE VIAS BAJAS, EN ENFERMOS AFECTOS DE OBSTRUCCION CRONICA AL FLUJO AEREO

    Revista Espanola de Quimioterapia, Vol. 2, Núm. 1, pp. 25-29

  3. Extrapulmonary tuberculosis in a University Hospital in Spain

    European Journal of Epidemiology, Vol. 5, Núm. 2, pp. 154-157

1987

  1. Comparative activity of new beta-lactams against anaerobes.

    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, Vol. 6, Núm. 2 Suppl, pp. 64-68

  2. Pharmacokinetic and microbiological profile of aztreonam.

    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, Vol. 6, Núm. 2 Suppl, pp. 281-283

1986

  1. Preliminary studies on bacteriophage typing of Mycobacterium tuberculosis strains isolated in Salamanca (Spain)

    European Journal of Epidemiology, Vol. 2, Núm. 3, pp. 178-181

1984

  1. In-vitro activity of norfloxacin against enterobacteriaceae and pseadomonas aeruginosa

    Journal of Antimicrobial Chemotherapy

1983

  1. Micobacteriosis causadas por especies del grupo III (Runyon). Experiencia personal.

    Revista Clinica Espanola, Vol. 168, Núm. 5, pp. 329-331

1982

  1. Activity of 19 cephalosporins against hospital and multiresistant aerobic strains

    Drugs under Experimental and Clinical Research, Vol. 8, Núm. 3, pp. 241-244

  2. Activity of β-hydroxy-piromidic acid against staphylococcus aureus and enterobacteriaceae

    Journal of Antimicrobial Chemotherapy

  3. In-vitro susceptibility of nocardia and rhodococcus to fourteen β-lactam antibiotics

    Journal of Antimicrobial Chemotherapy

  4. Inhibition coefficient of 12 disinfectants used in hospital practice

    Journal of Hospital Infection, Vol. 3, Núm. 4, pp. 375-378

  5. Use of the api zym system in the identification of mycobacterium fortuitum and mycobacterium chelonei

    Tubercle, Vol. 63, Núm. 3, pp. 209-211